Table 1.

Summary of patient samples xenotransplanted in NSG immunodeficient animals

Patient	Age	Gender	Sample	% of blasts	Karyotype	Engraftment	Mean %
AMKL1	6 mo	F	Fresh	20	46,XX, t(1;22)(p13;q13) [17]/46, idem, ider(11) add(11)(p14) t(11;12)(q11;q23) [2]/46,XX [1]	2/4	89.7
AMKL2	21 mo	M	Frozen	55	55, XY, +6, +9, t(9;11)(p22;q23), +10, +13, +19, +20, +21, +22, +22 [18] / 46, XY [2]	1/3	42.7
AMKL3	53 yr	M	Fresh	70	ND	0/4	NA
AMKL4	15 mo	M	Frozen	20	51-52 XY, t(2;7)(q23;q21), t(2;11)(p11;p11-12), +4, +6, +8, +9, +/− 10, del(13)(q12-q13.14), +21 [17]/ 52-53, idem, + 13 [2]/ 46, XY [1]	4/4	60.7
AMKL4R	26 mo	M	Fresh	75	ND	3/3	32.3
AMKL5	70 yr	F	Frozen	80	ND	0/4	NA
AMKL6	72 yr	M	Fresh	87	ND	1/4	16
AMKL7	42 mo	M	Frozen	80	ND	2/5	66.6

F, female; M, male; NA, not applicable; R, relapse. Age at diagnosis is indicated in months or years. “Mean %” indicates the mean percentage of human cells.